Moreover, immunohistochemistry was conducted to analyze CSCs markers (CD44 and CD24) and EMT markers (E-cadherin, β-catenin, vimentin, and N-cadherin) in benign breast lesions (control), paracancer tissues, and tumor tissues. The gene discussed is CDH1; the disease is neoplasm.